India-based Laurus Labs is preparing a huge factory to produce generic HIV drugs that CEO Satyanarayana Chava says will cost as little as 10% of what branded HIV drugs cost, in some cases. Laurus is already a large supplier of ingredients for antiretrovirals.
API manufacturer prepares to sell finished generics for HIV
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.